The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Anna Jakubowska

Department of Genetics and Pathology

International Hereditary Cancer Centre

Pomeranian Medical University

Polabska 4



Name/email consistency: medium



  • Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Polabska 4, Poland. 2010
  • International Hereditary Cancer Centre (IHCC), Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. 2008 - 2009
  • Pomeranian Medical University, Department of Genetics and Pathology, ul. Polabska 4, 70-115 Szczecin, Poland. 2002 - 2009


  1. The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers. Jakubowska, A., Rozkrut, D., Antoniou, A., Hamann, U., Lubinski, J. Breast Cancer Res. Treat. (2010) [Pubmed]
  2. Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Jakubowska, A., Jaworska, K., Cybulski, C., Janicka, A., Szymańska-Pasternak, J., Lener, M., Narod, S.A., Lubiński, J. Eur. J. Cancer (2009) [Pubmed]
  3. BARD1 and breast cancer in Poland. Jakubowska, A., Cybulski, C., Szymańska, A., Huzarski, T., Byrski, T., Gronwald, J., Debniak, T., Górski, B., Kowalska, E., Narod, S.A., Lubiński, J. Breast Cancer Res. Treat. (2008) [Pubmed]
  4. Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism. Jakubowska, A., Gronwald, J., Menkiszak, J., Górski, B., Huzarski, T., Byrski, T., Benner, A., Lubiński, J., Scott, R.J., Hamann, U. BMC. Cancer (2008) [Pubmed]
  5. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Jakubowska, A., Gronwald, J., Menkiszak, J., Górski, B., Huzarski, T., Byrski, T., Edler, L., Lubiñski, J., Scott, R.J., Hamann, U. Cancer Epidemiol. Biomarkers Prev. (2007) [Pubmed]
  6. Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. Jakubowska, A., Narod, S.A., Goldgar, D.E., Mierzejewski, M., Masojć, B., Nej, K., Huzarska, J., Byrski, T., Górski, B., Lubiński, J. Cancer Epidemiol. Biomarkers Prev. (2003) [Pubmed]
  7. A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer. Jakubowska, A., Scott, R., Menkiszak, J., Gronwald, J., Byrski, T., Huzarski, T., Górski, B., Cybulski, C., Debniak, T., Kowalska, E., Starzyńska, T., Ławniczak, M., Narod, S., Lubinski, J. Eur. J. Hum. Genet. (2003) [Pubmed]
  8. BRCA2 gene mutations in families with aggregations of breast and stomach cancers. Jakubowska, A., Nej, K., Huzarski, T., Scott, R.J., Lubiński, J. Br. J. Cancer (2002) [Pubmed]
WikiGenes - Universities